---
schema_version: "secwatch.filing_event.v1"
accession: "0001553350-25-000168"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:54:05.706256+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Board member Gabe Ling resigns from The Oncology Institute board effective Dec 1, 2025

## Summary
- Gabriel Ling resigned from the Board of Directors, effective December 1, 2025, with no disagreement with the company.
- Chairman Anne McGeorge thanked Ling for his service during TOI's early years as a public company.
- Formal search initiated for new independent directors with healthcare, clinical, and value-based care expertise.

## SEC filing metadata
- accession: 0001553350-25-000168
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/0001553350-25-000168-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000155335025000168/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001553350-25-000168
- JSON: https://secwatch.observer/filing/0001553350-25-000168.json
- Plain text: https://secwatch.observer/filing/0001553350-25-000168.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.